BEIJING, May 21 (Xinhua) -- Jiangxi Jemincare Group Co., Ltd. was selected into Xinhua News Agency's National Brands Project in Beijing on Monday.
The two sides will embark on cooperation in areas such as economic and financial information, think tank service, market research, credit evaluation, as well as overseas development.
Jiangxi Jemincare Group Co., Ltd. was selected into Xinhua News Agency's National Brands Project in Beijing on May 20th.
Li Yihai, chairman of Jiangxi Jemincare Group Co., Ltd., said that the group is speeding up brand building with plan to explore international market, and Xinhua News Agency's National Brands Project could help it to go global.
Jiangxi Jemincare Group Co., Ltd. is a leading pharmaceutical company focusing on Chinese medicine in China. Its products such as "Huang's Xiangsheng Pills" have a high share in niche markets, leading the industry's innovation and upgrade, according to Gu Yanfen, former secretary general of the All-China Federation of Industry and Commerce (ACFIC).
Headquartered in Nanchang, Jiangxi, the group has built industrial platforms and R&D institutes in Beijing, Shanghai, Jiangsu province and Zhejiang province. In 2017, the group’s revenue exceeded 23.7 billion yuan, ranking the tenth in the top 100 of Chinese medical industry.
Xinhua's National Brands Project was launched in June 2017, with the aim to further enhance brand influence of China's outstanding national enterprises mainly by its rich media resources. (Edited by Li Wenxin, liwenxin@xinhua.org)
A single purchase
